Primary Site >> Colorectal Cancer

Gene >> SPACA5

Journal: Mol Pharmacol. 1994 May;45(5):962-70.
Title: Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
Author: Sosinski, J|Thakar, J H|Germain, G S|Dias, P|Harwood, F C|Kuttesch, J F|Houghton, P J
PMID: 7910660
Journal: Anticancer Drugs. 1995 Apr;6(2):317-23.
Title: Efficacy of sulofenur and a second generation diarylsulfonylurea, N-[5-(2,3-dihydrobenzofuryl)sulfonyl]-N'-(3,4-dichlorophenyl)urea (LY295501), against colon adenocarcinoma xenografts.
Author: Houghton, P J|Cheshire, P J|Myers, L|Lutz, L|Toth, J|Grindey, G B|Houghton, J A
PMID: 7795279